Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADAR: Antipsychotic Reduction in Schizophrenia and Psychosis
NCT03559426Phase 4Completed
- Sponsor
- University College London
- Start
- Mar 2016
- Primary completion
- Mar 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in schizophrenia, schizoaffective disorder, delusional disorder and 1 more, sponsored by University College London. Primary endpoint: Social Functioning Scale at 24 months. Started Mar 2016; status: completed.
02
Conditions
schizophreniaschizoaffective disorderdelusional disorderpsychosis
Beyond the preview
Go deeper on NCT03559426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03559426.